Europe Allergy Treatment Market to Reach US$ 10,424.97 Mn at a CAGR of 7.1% in 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Allergy Treatment Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Allergy Treatment Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Allergy Cases Accelerate Demand for Anti-Allergic Drugs to Favor Market

5.2 Market Opportunities

5.2.1 New Drug Approvals for Allergy Treatment Provide Lucrative Market Opportunity

5.3 Future Trends

5.3.1 Rising Research & Development (R&D) activities are likely to remain key trends in the market

5.4 Impact of Drivers and Restraints

6. Europe Allergy Treatment Market Regional Analysis

6.1 Europe Allergy Treatment Market Overview

6.2 Europe Allergy Treatment Market Revenue 2018-2028 (US$ Million)

6.3 Europe Allergy Treatment Market Forecast Analysis

7. Europe Allergy Treatment Market Analysis – by Allergy Type

7.1 Eye Allergy

7.1.1 Overview
7.1.2 Eye Allergy: Europe Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Rhinitis

7.2.1 Overview
7.2.2 Rhinitis: Europe Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Asthma

7.3.1 Overview
7.3.2 Asthma: Europe Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Skin Allergy

7.4.1 Overview
7.4.2 Skin Allergy: Europe Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Food Allergies

7.5.1 Overview
7.5.2 Food Allergies: Europe Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Other Allergies

7.6.1 Overview
7.6.2 Other Allergies: Europe Allergy Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Allergy Treatment Market Analysis – by Treatment

8.1 Anti-Allergy Drugs and Immunotherapy

8.1.1 Overview
8.1.2 Anti-Allergy Drugs and Immunotherapy : Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Allergy Treatment Market – Europe Analysis

9.1 Europe

9.1.1 Europe Allergy Treatment Market Breakdown, by Key Country, 2021 and 2028 (%)
9.1.1.1 Europe Allergy Treatment Market – Revenue and Forecast Analysis – by Country
9.1.1.1 UK: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 UK: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.1.1.1.2 UK: Europe Allergy Treatment Market Breakdown, by Treatment

9.1.1.2 Germany: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Germany: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.1.1.2.2 Germany: Europe Allergy Treatment Market Breakdown, by Treatment

9.1.1.3 France: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 France: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.1.1.3.2 France: Europe Allergy Treatment Market Breakdown, by Treatment

9.1.1.4 Russia: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Russia: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.1.1.4.2 Russia: Europe Allergy Treatment Market Breakdown, by Treatment

9.1.1.5 Italy: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 Italy: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.1.1.5.2 Italy: Europe Allergy Treatment Market Breakdown, by Treatment

9.1.1.6 Rest of Europe: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Rest of Europe: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.1.1.6.2 Rest of Europe: Europe Allergy Treatment Market Breakdown, by Treatment

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Europe Allergy Treatment Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 LETI Pharma

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Dermapharm Holding Se

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Johnson and Johnson Services, Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Sanofi

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 AbbVie's Inc.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Pfizer

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 ALK-Abelló A/S

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Allergy Therapeutics

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Stallergenes Greer

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 GlaxoSmithKline PLC

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights